Raul Mena

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole

Adam Brufsky, Nigel Bundred, Robert E. Coleman et al. · The Oncologist · 2008 · 175 citations

Medicine, Oncology, Pharmacology +17

Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue

Dominick Sinicropi, Kunbin Qu, François Collin et al. · PLoS ONE · 2012 · 88 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

L. C. Scott, James C. Yao, A.B. Benson et al. · Cancer Chemotherapy and Pharmacology · 2008 · 79 citations

Medicine, Oncology, Pharmacology +15

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kevin R. Kelly, Jonathan W. Friedberg, Steven Park et al. · Clinical Cancer Research · 2018 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17